Meso Scale Diagnostics is a global leader in the development, manufacture, and commercialization of assays and instruments for measuring molecules in biological samples. Founded in 1995, the company operates with a worldwide presence, serving clients in the pharmaceutical, government, university, and clinical laboratory sectors. Its technologies support applications in medical research, drug development, and personalized medicine.
The company's core platform is its proprietary MULTI-ARRAY technology, which enables the simultaneous profiling of many biomarkers in a single sample with high sensitivity and reproducibility. Its electrochemiluminescence-based detection system provides unsurpassed sensitivity and multiplex functionality for biological assays.
Meso Scale Diagnostics' technical expertise spans bioanalytics, immunoassays, electrochemiluminescence, multiplexing, biomarker profiling, and clinical diagnostics. The company's products are used in the development of companion diagnostics and in research environments where precise molecular measurement is critical.
